Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870; TTY/TDD Users 1-800-735-2258 - [E-mail Us]

DOCKETS ENTERED on September 24, 2002

TABLE OF CONTENTS

Hyper links are part of the Docket  title - not all dockets/documents are linked

NOTE:  Documents received by the Dockets Management Branch "MAY" be posted on the Internet. PLEASE DO NOT include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence.

[FDA DOCKETS PAGE] [FDA HOME PAGE]  [ ITEM CODES ]

 
86F-0208 MYCO-PROTEIN DERIVED - FUSARIUM GRANINEARUM SOURCE PRO *
00N-1571 Enrofloxacin for Poultry: Opportunity for hearing *
01P-0120 Ban Unsafe IV Catheters and other Devices *
02D-0307 Potassium Chloride Modified-Release Tablets and Capsules *
02D-0350 Handling and Retention of Bioavailability and Bioequivalence *
02P-0292 Health Claims: Walnuts & Cornary Disease *
02P-0419 Amiodarone Hydrochloride Injection 50mg/mL *
02P-0422 Propoxyphene Napsylate and Acetaminophen 100mg/35mg and 100m *

86F-0208 MYCO-PROTEIN DERIVED FROM FUSARIUM GRANINEARUM SOURCE PRO

ANS 1 HFS-200 to CSPI Vol#: 1

00D-1598 Voluntary Labeling for Bioengineered Foods

C 9831 Nina Eusanu Vol#: 572

00N-1571 Enrofloxacin for Poultry: Opportunity for hearing

SUP 7 Bayer & AHI Vol#: 270

01F-0047 Foodborne pathogens in raw-frozen-cooked-partially cooked

EMC 349 Steve Huse Vol#: 6

EMC 350 Melissa Lombardo Vol#: 6

EMC 351 Jeremy Scott Vol#: 6

EMC 352 Megan Livingston Vol#: 6

EMC 353 Laida Aguirre Vol#: 6

EMC 354 Barbara Labrecque Vol#: 6

01P-0120 Ban Unsafe IV Catheters and other Devices

C 27 Novo Nordisk Pharmaceuticals, Inc. Vol#: 1

01P-0345 Listing the color additive yellow #5 for use in food/Drug

EMC 1118 Diana Stanford Vol#: 5

EMC 1119 Alane Redon Vol#: 5

02D-0307 Potassium Chloride Modified-Release Tablets and Capsules

C 1 MDS Pharma Services Vol#: 1

02D-0350 Handling and Retention of Bioavailability and Bioequivalence

C 4 AstraZeneca Pharmaceuticals, LP Vol#: 1

C 5 Bayer Corporation Vol#: 1

02N-0359 Protection of Human Subjects in Clinical Trials

NM 1 Vol#: 1

02N-0393 Draft Action Plan on Acrylamide

NCR 1 Vol#: 1

02P-0292 Health Claims: Walnuts & Cornary Disease

C 1 Center for Genetics Nutrition and Health Vol#: 6

02P-0419 Amiodarone Hydrochloride Injection 50mg/mL

ACK 1 HFA-305 Vol#: 1

CP 1 Bioniche Pharma Group Limited Vol#: 1

02P-0422 Propoxyphene Napsylate and Acetaminophen 100mg/35mg and 100m

ACK 1 HFA-305 Vol#: 1

CP 1 Frommer Lawrence & Haug, LLP Vol#: 1